Estudio exploratorio de la participación en proyectos de investigación en Farmacias Comunitarias

Carlos Fuentes-Senise; Francisco Javier Ferreira Alfaya; Maria Elena Senise-Gómez; Español

doi:10.30827/ars.v63i2.23641

Authors

Carlos Fuentes-Senise Farmacéutico comunitario. Farmacia Puente Ladrillo. Salamanca, España. https://orcid.org/0000-0002-6425-7556
Francisco Javier Ferreira Alfaya Farmacéutico en Servicios Médicos del Centro Penitenciario de Melilla. Melilla España. https://orcid.org/0000-0002-6805-0608
Maria Elena Senise-Gómez Médico de Atención Primaria. Centro de salud Aldaeadávila de la Ribera. Aldeadávila de la Ribera, Salamanca, España. https://orcid.org/0000-0002-7732-3399
Español Hospital Universitario Virgen de las Nieves, Unidad de Farmacogenética Granada, España. https://orcid.org/0000-0001-5038-0708

DOI:

https://doi.org/10.30827/ars.v63i2.23641

Keywords:

Patient participation, Community pharmacy, Research subjects

Abstract

Introduction: Over the last years there has been an increase in community pharmacy participation in research projects. Patient recruitment plays a key role in the research project success. Pharmacists’ barriers and enablers of recruitment have been identified, but little is known about the influence of research project-related factors. The aim of this paper is to explore patient participation in different studies conducted in community pharmacies and to identify study-specific factors that may be associated with it.

Method: An experimental multicenter study was performed in 12 community pharmacies participating in 4 research projects. The number of patients who accepted/refused to participate was recorded. Variables related to each offered study and the project were collected. A bivariate analysis using Pearson’s Chi-Square test and a risk analysis were performed.

Results: Participation rate was 90.44% (n=558). Study type (OR=2.64; 95%IC=1.47-4.75; cross-sectional vs pragmatic), the type of measurement applied (OR=2.47; 95%CI=1.43-4.36), the use of a personalized care area (PCA) (OR=2.49; 95%CI=1.44-4.39), and personal data request (OR=2.53; 95%CI=1.47-4.42) showed association with participation in the RP (p<0.05).

Conclusions: Patient participation in research projects is high and appears to rely on study-specific factors.

Downloads

Download data is not yet available.

References

Andrés Iglesias JC, Andrés Rodríguez NF, Fornos Pérez JA. Community pharmacy-based research in Spain (1995-2005): A bibliometric study. Pharm Pract Internet 2007;5:21–30. Doi: 10.4321/s1886-36552007000100004.

Saavedra-Mitjans M, Ferrand É, Garin N, Bussières J-F. Role and impact of pharmacists in Spain: a scoping review. Int J Clin Pharm 2018;40:1430–42. Doi: 10.1007/s11096-018-0740-7.

García-Cárdenas V, Gastelurrutia MA, Malet-Larrea A, Peiró T, Pérez-Escamilla B, Saez-Escamilla B, et al. AdherenciaMED Project: Design, impact assessment and implementation of a professional service for therapeutic adherence at the community pharmacy setting. Madrid: Consejo General de Colegios Oficiales de Farmacéuticos ; 2019 ISBN: 978-84-87089-12-1

Castillo D, Burgos F, Gascón MP. El papel de las farmacias comunitarias en el control de las enfermedades respiratorias. Archivos De Bronconeumología 2015;51:429–30. Doi: 10.1016/j.arbres.2015.06.003.

Melton BL, Lai Z. Review of community pharmacy services: what is being performed, and where are the opportunities for improvement? Integr Pharm Res Pract 2017;6:79–89. Doi: 10.2147/iprp.s107612.

Bertilsson E, Serhal S, Emmerton L, Bosnic-Anticevich S, Krass I, Bereznicki B, et al. Pharmacists experience of and perspectives about recruiting patients into a community pharmacy asthma service trial. Res Soc Administrative Pharm 2021;17:595–605. Doi: 10.1016/j.sapharm.2020.05.012.

Crilly P, Patel N, Ogunrinde A, Berko D, Kayyali R. Community Pharmacists’ Involvement in Research in the United Kingdom. Pharm 2017;5:48. Doi: 10.3390/pharmacy5030048.

Gastelurrutia MA, Benrimoj SIC, Castrillon CC, Amezua MJC de, Fernandez-Llimos F, Faus MJ. Facilitators for practice change in Spanish community pharmacy. Pharm World Sci 2009;31:32–9. Doi: 10.1007/s11096-008-9261-0.

Kypri K, Samaranayaka A, Connor J, Langley JD, Maclennan B. Non-response bias in a web-based health behaviour survey of New Zealand tertiary students. Prev Med 2011;53:274–7. Doi: 10.1016/j.ypmed.2011.07.017.

Madigan MP, Troisi R, Potischman N, Brogan D, Gammon MD, Malone KE, et al. Characteristics of respondents and non-respondents from a case-control study of breast cancer in younger women. Int J Epidemiol 2000;29:793–8. Doi: 10.1093/ije/29.5.793.

Arfken CL, Balon R. Declining Participation in Research Studies. Psychother Psychosom 2011;80:325–8. Doi: 10.1159/000324795.

Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to Participation in Randomised Controlled Trials A Systematic Review. J Clin Epidemiol 1999;52:1143–56. Doi: 10.1016/s0895-4356(99)00141-9.

Bower P, Brueton V, Gamble C, Treweek S, Smith CT, Young B, et al. Interventions to improve recruitment and retention in clinical trials: a survey and workshop to assess current practice and future priorities. Trials 2014;15:399. Doi: 10.1186/1745-6215-15-399.

Groth SW. Honorarium or coercion: use of incentives for participants in clinical research. J New York State Nurses’ Assoc n.d.;41:11–3; quiz 22.

Qudah B, Thakur T, Chewning B. Factors Influencing Patient Participation in Medication Counseling at the Community Pharmacy: A Systematic Review. Res Soc Administrative Pharm 2021;17:1863–76. Doi: 10.1016/j.sapharm.2021.03.005.

Macfarlane H, Maidment I. Recruiting people with severe mental illness through community pharmacies: real-world experiences from a UK study. Bmc Fam Pract 2020;21:172. Doi: 10.1186/s12875-020-01243-5.

Stewart D, Madden M, Dongen AV, Watson M, Morris S, Whittlesea C, et al. Process study within a pilot cluster randomised trial in community pharmacy: An exploration of pharmacist readiness for research. Res Soc Administrative Pharm 2021;17:1750–7. Doi: 10.1016/j.sapharm.2021.01.005.